Chorea News and Research

RSS
Neurocrine to advance its NBI-98854 VMAT2 Inhibitor into a multiple repeated dose Phase 1 study

Neurocrine to advance its NBI-98854 VMAT2 Inhibitor into a multiple repeated dose Phase 1 study

Cedars-Sinai Regenerative Medicine Institute supplies stem cells to aid Huntington's disease research

Cedars-Sinai Regenerative Medicine Institute supplies stem cells to aid Huntington's disease research

NIH awards Gladstone Institute consortium $3.7M for Huntington's disease research

NIH awards Gladstone Institute consortium $3.7M for Huntington's disease research

HDSA honors outstanding contributors against Huntington's Disease

HDSA honors outstanding contributors against Huntington's Disease

Neurologix to showcase novel gene transfer approach to Parkinson’s disease

Neurologix to showcase novel gene transfer approach to Parkinson’s disease

New insights into identifying children at risk for autoimmune brain disorders

New insights into identifying children at risk for autoimmune brain disorders

Biovail acquires worldwide rights to Tetrabenazine

Biovail acquires worldwide rights to Tetrabenazine

First drug for Huntington's disease approved for use in the U.S.

First drug for Huntington's disease approved for use in the U.S.

FDA approves tetrabenazine for Huntington's disease

FDA approves tetrabenazine for Huntington's disease

Schizophrenia improved by mental and physical exercise

Schizophrenia improved by mental and physical exercise

Tetrabenazine protects brain cells in Huntington's disease model

Tetrabenazine protects brain cells in Huntington's disease model

Synaptic dysfunction in Huntington's disease

Synaptic dysfunction in Huntington's disease

Bioluminescence part of new imaging technique

Bioluminescence part of new imaging technique

New treatment possibilities for Huntington's disease

New treatment possibilities for Huntington's disease

Researchers discover protein interaction that may explain how Huntington's disease affects the brain

Researchers discover protein interaction that may explain how Huntington's disease affects the brain

Protection for nerve cells - eating up defective proteins

Protection for nerve cells - eating up defective proteins

Green tea slows down plaque formation in Huntington's disease

Green tea slows down plaque formation in Huntington's disease

Molecular chaperones protect cells

Molecular chaperones protect cells

Skin test may help detect early Alzheimer's

Skin test may help detect early Alzheimer's

Tetrabenazine cuts down involuntary movements in Huntington's disease

Tetrabenazine cuts down involuntary movements in Huntington's disease